Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

Eur Heart J. 2016 Apr 1;37(13):1015-23. doi: 10.1093/eurheartj/ehv505. Epub 2016 Mar 16.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Atrial Fibrillation / complications
  • Cardiovascular Diseases / chemically induced*
  • Cyclooxygenase Inhibitors / adverse effects
  • Drug Approval
  • Drug Therapy, Combination
  • Fibrinolytic Agents / adverse effects
  • Heart Failure / complications
  • Hemostasis / drug effects
  • Humans
  • Intraoperative Complications / chemically induced
  • Myocardial Infarction / complications
  • Observational Studies as Topic
  • Public Health
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Risk Factors
  • Safety-Based Drug Withdrawals

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Fibrinolytic Agents